Q1 2025 Management View CEO Tom Lin reported continued progress in advancing Tinlarebant for Stargardt's disease and ...

Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ETCompany ParticipantsJulie Fallon - Investor RelationsTom Lin ...

The Hollow Half' by Sarah Aziza isn't just about her eating disorder and recovery. Here, she explains why her story, like its ...

Swedish green tech company Lignin Industries AB has raised €3.9 million in fresh funding; as the company accelerates its ...

The winner, WFB announced with unfeigned delight, was Sam Tanenhaus and he had won the sweepstakes for two reasons: First, he had written a book about Whittaker Chambers that WFB had admired. And ...

Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet ...

The Food and Drug Administration is drawing up plans that would end most of its routine food ... two officials said. For example, agency staff currently conduct annual visits to infant formula ...

providing end-to-end services across drug discovery, preclinical, and clinical development. Through the partnership, CN Bio will install PhysioMimix instruments at Pharmaron’s facilities across ...

The first book I remember reading in its entirety was a biography. It was the story of ... we call it “Good.” The end of Jesus’ life wasn’t unique in that he died, but why he died, and ...

“Unither’s success is a shining example of the innovation happening across our ecosystem ... Therapeutics’ mission to address the unmet medical needs of patients with end-stage organ diseases.